Literature DB >> 17468920

Prognostic factors after resection for hepatocellular carcinoma in nonfibrotic or moderately fibrotic liver. A 116-case European series.

Thierry Bège1, Y Patrice Le Treut, Jean Hardwigsen, Pascal Ananian, Hubert Richa, Pierre Campan, Stéphane Garcia.   

Abstract

The purpose of this study was to identify factors influencing prognosis after resection for hepatocellular carcinoma in the noncirrhotic liver and to measure the impact of moderate fibrosis on presentation and prognosis. A series of 116 primary procedures were performed for hepatocellular carcinoma in the noncirrhotic liver. These cases accounted for 42% of hepatic resections performed for hepatocellular carcinoma during the study period (1987-2005). Seventy-seven cases (58%) occurred in patients with nonfibrotic livers (Metavir score F0). The mean age was 61 years. The sex ratio was 3.5, with a female predominance before 50 years. Hepatitis B virus (HBV) or hepatitis C virus infection was found in 30% of patients. Symptoms were present in 64% of cases. Elevated serum alpha fetoprotein levels were observed in 44% of cases. Procedures involved minor hepatectomy in 40 cases, major hepatectomy in 72 cases, and transplantation in 4 cases. Postoperative mortality was 6% and morbidity was 31%. Complete resection was achieved in 90% of cases. The tumor was isolated in 72% of cases. The mean tumor diameter was 10.6 cm. Vascular invasion was observed in 48% of cases. Hepatocellular carcinoma in the nonfibrotic liver was associated with younger age and female sex, but there was no difference with other hepatocellular carcinoma with regard to histological or prognostic features. With a median follow-up of 79 months, overall survival was 40% for a median of 41 months. Multivariate analysis identified incomplete resection, vascular invasion, and HBV infection as independent factors of poor prognosis. In case of recurrence, repeat resection was feasible in 30% of cases with 69% survival at 5 years. Although hepatocellular carcinoma in the noncirrhotic liver is generally diagnosed at an advanced stage, its resectability remains high. As a result, hepatocellular carcinoma in the noncirrhotic liver accounts for a large proportion of cases in surgical series and has a better prognosis than hepatocellular carcinoma in the cirrhotic liver. Vascular invasion, incomplete resection, and HBV infection are independent factors of poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17468920     DOI: 10.1007/s11605-006-0023-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.267


  24 in total

1.  An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group.

Authors:  P Bedossa; T Poynard
Journal:  Hepatology       Date:  1996-08       Impact factor: 17.425

2.  Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver.

Authors:  Christophe Laurent; Jean Frédéric Blanc; Steeve Nobili; Antonio Sa Cunha; Brigitte le Bail; Paulette Bioulac-Sage; Charles Balabaud; Maylis Capdepont; Jean Saric
Journal:  J Am Coll Surg       Date:  2005-08-31       Impact factor: 6.113

3.  Management of hepatocellular carcinoma.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

Review 4.  Cirrhosis and the aetiology of hepatocellular carcinoma.

Authors:  P J Johnson; R Williams
Journal:  J Hepatol       Date:  1987-02       Impact factor: 25.083

5.  [Hepatocellular carcinoma in a non-cirrhotic liver. Presentation of series of 77 operated patients].

Authors:  Y P Le Treut; J Pons; J Hardwigsen; P Castellani; P Campan; X Hanna; S Garcia
Journal:  Chirurgie       Date:  1999-11

6.  Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.

Authors:  R P Beasley; L Y Hwang; C C Lin; C S Chien
Journal:  Lancet       Date:  1981-11-21       Impact factor: 79.321

7.  Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus.

Authors:  M Minagawa; M Makuuchi; T Takayama; K Ohtomo
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

8.  Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis.

Authors:  H Lang; G C Sotiropoulos; M Dömland; N R Frühauf; A Paul; J Hüsing; M Malagó; C E Broelsch
Journal:  Br J Surg       Date:  2005-02       Impact factor: 6.939

9.  Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis.

Authors:  Miin-Fu Chen; Hsiu-Pei Tsai; Long-Bin Jeng; Wei-Chen Lee; Chun-Nan Yeh; Ming-Chin Yu; Chao-Ming Hung
Journal:  World J Surg       Date:  2003-04       Impact factor: 3.352

10.  Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections.

Authors:  H Bismuth; L Chiche; D Castaing
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

View more
  9 in total

1.  Laparoscopic resection for hepatocellular carcinoma: eastern and western experiences.

Authors:  Paulo Herman; Fabricio Ferreira Coelho
Journal:  Chin J Cancer Res       Date:  2014-06       Impact factor: 5.087

2.  Recurrence of hepatocellular carcinoma in noncirrhotic liver after hepatectomy.

Authors:  Laurence Chiche; B Menahem; C Bazille; V Bouvier; L Plard; V Saguet; A Alves; E Salame
Journal:  World J Surg       Date:  2013-10       Impact factor: 3.352

3.  Long-term survival with repeated resections of recurrent hepatocellular carcinoma in a non-cirrhotic liver: case report and brief review of the literature.

Authors:  Christopher Hadjittofi; Panagiotis G Athanasopoulos; Rahul S Koti; Sofia K Konstantinidou; Brian R Davidson
Journal:  Ann Transl Med       Date:  2016-03

4.  Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.

Authors:  Anna S Lok; Leonard B Seeff; Timothy R Morgan; Adrian M di Bisceglie; Richard K Sterling; Teresa M Curto; Gregory T Everson; Karen L Lindsay; William M Lee; Herbert L Bonkovsky; Jules L Dienstag; Marc G Ghany; Chihiro Morishima; Zachary D Goodman
Journal:  Gastroenterology       Date:  2008-09-18       Impact factor: 22.682

5.  The impact of liver fibrosis on microvascular invasion and prognosis of hepatocellular carcinoma with a solitary nodule: a Surveillance, Epidemiology, and End Results (SEER) database analysis.

Authors:  En Lin; Baojia Zou; Guifang Zeng; Chaonong Cai; Peiping Li; Jiafan Chen; Decheng Li; Baimeng Zhang; Jian Li
Journal:  Ann Transl Med       Date:  2021-08

Review 6.  Hepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia-Pacific region.

Authors:  Mi Na Kim; Beom Kyung Kim; Kwang-Hyub Han
Journal:  J Gastroenterol       Date:  2013-03-06       Impact factor: 7.527

7.  Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver.

Authors:  Kerstin Schütte; Christian Schulz; Janine Poranzke; Kai Antweiler; Jan Bornschein; Tina Bretschneider; Jörg Arend; Jens Ricke; Peter Malfertheiner
Journal:  BMC Gastroenterol       Date:  2014-07-03       Impact factor: 3.067

Review 8.  Surgical Treatment of Hepatocellular Carcinoma.

Authors:  Daniel Zamora-Valdes; Timucin Taner; David M Nagorney
Journal:  Cancer Control       Date:  2017 Jul-Sep       Impact factor: 3.302

Review 9.  Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review.

Authors:  Aakash Desai; Sonia Sandhu; Jin-Ping Lai; Dalbir Singh Sandhu
Journal:  World J Hepatol       Date:  2019-01-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.